1. Home
  2. CIF vs LSTA Comparison

CIF vs LSTA Comparison

Compare CIF & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIF
  • LSTA
  • Stock Information
  • Founded
  • CIF 1988
  • LSTA 1980
  • Country
  • CIF United States
  • LSTA United States
  • Employees
  • CIF N/A
  • LSTA N/A
  • Industry
  • CIF Trusts Except Educational Religious and Charitable
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • CIF Finance
  • LSTA Health Care
  • Exchange
  • CIF Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • CIF 31.5M
  • LSTA 31.2M
  • IPO Year
  • CIF N/A
  • LSTA N/A
  • Fundamental
  • Price
  • CIF $1.75
  • LSTA $2.51
  • Analyst Decision
  • CIF
  • LSTA Strong Buy
  • Analyst Count
  • CIF 0
  • LSTA 1
  • Target Price
  • CIF N/A
  • LSTA $15.00
  • AVG Volume (30 Days)
  • CIF 43.9K
  • LSTA 58.9K
  • Earning Date
  • CIF 01-01-0001
  • LSTA 02-27-2025
  • Dividend Yield
  • CIF 10.11%
  • LSTA N/A
  • EPS Growth
  • CIF N/A
  • LSTA N/A
  • EPS
  • CIF N/A
  • LSTA N/A
  • Revenue
  • CIF N/A
  • LSTA N/A
  • Revenue This Year
  • CIF N/A
  • LSTA N/A
  • Revenue Next Year
  • CIF N/A
  • LSTA N/A
  • P/E Ratio
  • CIF N/A
  • LSTA N/A
  • Revenue Growth
  • CIF N/A
  • LSTA N/A
  • 52 Week Low
  • CIF $1.47
  • LSTA $2.19
  • 52 Week High
  • CIF $1.77
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • CIF 53.38
  • LSTA 40.33
  • Support Level
  • CIF $1.73
  • LSTA $2.51
  • Resistance Level
  • CIF $1.76
  • LSTA $2.66
  • Average True Range (ATR)
  • CIF 0.02
  • LSTA 0.19
  • MACD
  • CIF 0.00
  • LSTA -0.01
  • Stochastic Oscillator
  • CIF 75.00
  • LSTA 17.50

About CIF MFS Intermediate High Income Fund

Mfs Intermediate High Income Fund is a United States based diversified closed-end management investment company. Its investment objective is to seek high current income but may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment grade corporate bonds, government securities and other securities.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

Share on Social Networks: